Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | BMY | AMGN | GILD | ILMN |
| Company | Crispr Therapeutics Ag | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 57.00 | 43.98 | 301.75 | 65.43 | 119.00 |
| High | 57.00 | 44.20 | 301.84 | 65.84 | 119.42 |
| Low | 56.18 | 43.98 | 300.01 | 65.16 | 117.90 |
| Last | 55.79 | 44.00 | 301.28 | 65.43 | 116.57 |
| Change | -1.27 | +0.10 | +1.80 | -0.11 | -2.41 |
| % Change | -2.23% | +0.23% | +0.60% | -0.17% | -2.03% |
| Volume | 59,916 | 504,791 | 123,660 | 250,444 | 55,250 |
| 20-Day Average Volume | 1,264,661 | 13,858,715 | 2,707,778 | 7,252,477 | 1,420,868 |
| Previous Close | 57.06 | 43.90 | 299.48 | 65.54 | 118.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 56.51 | 46.73 | 275.34 | 66.46 | 122.15 |
| 20-Day Raw Stochastic | 35.27% | 9.39% | 66.01% | 19.15% | 14.41% |
| 20-Day Relative Strength | 39.89% | 30.20% | 63.57% | 34.18% | 41.14% |
| Weighted Alpha | -24.26 | -36.02 | +28.88 | -20.29 | -40.05 |
| Today's Opinion | 56% Sell | 100% Sell | 40% Buy | 100% Sell | 88% Sell |
| Previous Opinion | 24% Sell | 100% Sell | 24% Buy | 100% Sell | 88% Sell |
| Last Month's Opinion | 24% Buy | 32% Sell | 24% Sell | 100% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.40% since 04/30/24 | +0.32% since 04/30/24 | +10.08% since 04/30/24 | +0.26% since 04/30/24 | -3.71% since 04/30/24 |
| Low | 52.74 on 05/01/24 | 43.33 on 05/02/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 115.91 on 05/06/24 |
| High | 58.45 on 05/03/24 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | -10.37% since 04/05/24 | -14.11% since 04/05/24 | +11.71% since 04/05/24 | -6.05% since 04/05/24 | -7.25% since 04/05/24 |
| Low | 52.73 on 04/30/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 115.73 on 04/18/24 |
| High | 65.24 on 04/09/24 | 51.68 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | -14.21% since 02/07/24 | -9.37% since 02/07/24 | +1.92% since 02/07/24 | -12.16% since 02/07/24 | -17.11% since 02/07/24 |
| Low | 52.73 on 04/30/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 115.73 on 04/18/24 |
| High | 91.10 on 02/22/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | -3.76% since 11/07/23 | -15.70% since 11/07/23 | +11.23% since 11/07/23 | -18.91% since 11/07/23 | +3.48% since 11/07/23 |
| Low | 48.55 on 11/13/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.00 on 11/10/23 |
| High | 91.10 on 02/22/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,843,425 | 88,989,688 | 160,633,888 | 81,602,352 | 18,948,162 |
| Shares Outstanding, K | 84,883 | 2,027,100 | 536,376 | 1,245,077 | 159,255 |
| Annual Sales | 371,210,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -153,610,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 201,210,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 1,076,000,000 |
| Last Quarter Net Income | 89,350,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | -126,000,000 |
| 60-Month Beta | 1.80 | 0.45 | 0.60 | 0.22 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.10 on 02/21/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.90 | 16.71 | 16.07 | 134.01 |